Professor Andrew Boyd
Professor of Experimental Haematology
Head Leukaemia Foundation Research Unit
Professor Andrew Boyd
Born in Melbourne in 1948, Professor Andrew Boyd received his B.Med.Sc in 1970, followed by an MBBS in 1973 and a PhD in 1981 - all from Melbourne University (MU). He became a Fellow of the Royal Australasian College of Physicians in 1983. From 1974 to 1978 he worked as Resident Medical Officer, Royal Melbourne Hospital (RMH), and then Medical Registrar, followed by a position as Haematology Registrar with Austin Hospital, Melbourne.
Professor Boyd undertook an NH&MRC postgraduate fellowship with Professor Sir Gustav Nossal at the Walter and Eliza Hall Institute (WEHI). After a period as the Lyndal Skea Leukaemia Research fellow in the laboratory of Professor Don Metcalf he moved to the Dana Farber Cancer Institute at Harvard Medical School to study lymphomas.
He returned to Australia as a laboratory head at WEHI, studying proteins expressed by leukaemia and lymphomas. He was also appointed Head of the Monoclonal Antibody Laboratory, Collaborative Research Centre for Cellular Growth Factors in 1992.
In 1996 he was appointed as Senior Principal Research Fellow and Head, Leukaemia Foundation Research Unit, Leukocyte Biology unit; Professor of Experimental Haematology, University of Queensland; Chairman, Joint Program for Experimental Haematology at the Queensland Institute of Medical Research (QIMR) and the University of Queensland and consultant haematologist, Department of Haematology at the Royal Brisbane Hospital.
In 2000 he was appointed as Assistant Director of QIMR with special responsibilities for translational and clinical research.
Professor Boyd is the chair of the Leukaemia Foundation’s Grant Review Committee and a member of the National Medical and Scientific Advisory Committee.
